C6-ceramide maintains elevated cytosolic calcium levels in activated platelets

Thrombosis Research

Volumn 81, Issue 2, 1996, Pages 219-229

  Wong, Kenneth ^a,b   Li, Xue Bin ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b Research Department   (Canada)

Author keywords

Calcium; Ceramide; Inositol phosphate; Platelets

Indexed keywords

CALCIUM; CALYCULIN A; CERAMIDE; INOSITOL TRISPHOSPHATE; PHORBOL ESTER;

ARTICLE; CONTROLLED STUDY; CYTOSOL; HUMAN; HUMAN CELL; METABOLISM; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION;

BLOOD PLATELETS; CALCIUM; CERAMIDES; CYTOSOL; HUMANS; INOSITOL PHOSPHATES; MANGANESE; PHOSPHORYLATION; PLATELET AGGREGATION; PROTEIN KINASE C; TETRADECANOYLPHORBOL ACETATE; THROMBIN;

EID: 0029983539     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(95)00239-1     Document Type: Article

References (26)

1. MATHIAS, S. and KOLESNICK, R. Ceramide: a novel second messenger. Adv. Lipid Res. 25, 65-90, 1993.
2. HANNUN, Y.A., OBEID, L.M., and WOLFF, R.A. The novel second messenger ceramide: identification, mechanism of action, and cellular activity. Adv. Lipid Res. 25, 43-64, 1993.
3. DOBROWSKY, R.T., and HANNUN, Y.A. Ceramide-activated protein phosphatase: partial purification and relationship to protein phosphatase 2A. Adv. Lipid Res. 25, 91-104, 1993.
4. 2-ceramide) inhibited neutrophil superoxide formation and calcium influx. J. Biol. Chem. 270, 3056-3062, 1995.
5. PUTNEY, J.W. Jr. The capacitative model for receptor-activated calcium entry. Adv. Pharmacol. 22, 251-269, 1991.
6. 2+ influx. Nature 364, 809-814, 1993.
7. 2+. J. Biol. Chem. 270, 29-32, 1995.
8. SAGE, S.O., SARGEANT, P., HEEMSKERK, J.W., and MAHAUT-SMITH M.P. Calcium influx mechanisms and signal organization in human platelets. Adv. Exp. Med. Bio. 344, 69-82, 1993.
9. TURKSON, J., LI, X-B, and WONG, K. Staurosporine induces hydrolysis of phosphatidyl inositol 4,5-bisphosphate in human platelets. FEBS Lett. 393, 37-41, 1994.
10. LAPETINA, E.G., and SIESS, W. Measurement of inositol phospholipid turnover in platelets. Meth. Enzymol. 141, 176-193, 1987.
11. POLLOCK, W.K., RINK, T.J., and IRVINE, R.F. Liberation of [3H]arachidonic acid and changes in cytosolic free calcium in fura-2-loaded human platelets stimulated by ionomycin and collagen. Biochem. J. 235, 869-877, 1986.
12. 2+ levels of human neutrophils. Biochem. J. 283, 499-505, 1992.
13. PARENTE, J.E., WALSH, M., GIRARD, P., KUO, J.F., NG, D. and WONG, K. Gold coordinate complexes inhibit protein kinase C. Molec. Pharmacol., 35, 26-33, 1989.
14. RINK, T.J., and SAGE, S.O. Calcium signalling in human platelets. Annu. Rev. Physiol. 52, 431-449, 1990.
15. 2+ mobilization in human platelet. Eur. J. Biochem. 205, 1003-1009, 1992.
16. 2+ uptake in the intact human platelet by increasing the Vm of the Ca(2+)-ATPase pump. Biochim. Biophys. Acta 1107, 213-222, 1992.
17. BISHOP, W.R., PACHTER, J.A., and PAI, J.K. Regulation of phospholipid hydrolysis and second messenger formation by protein kinase C. Advances Enzyme Regulation. 32, 177-192, 1992.
18. 2+-transients in human platelets. Biochemistry 31, 6553-6561, 1992.
19. 2+ influx of human platelets. J. Cell. Biochem. 51, 442-445, 1993.
20. SIESS, W. Molecular mechanisms of platelet activation. Physiol. Rev. 69, 58-178, 1989.
21. KING, W.G., and RITTENHOUSE, S.E. Inhibition of protein kinase C by staurosporine promotes elevated accumulations of inositol trisphosphates and tetrakisphosphate in human platelets exposed to thrombin. J. Biol. Chem. 264, 6070-6074, 1989.
22. KING, W.G., DOWNES, C.P., PRESTWICH, G.D., and RITTENHOUSE, S.E. Ca2(+)-stimulatable and protein kinase C-inhibitable accumulation of inositol 1,3,4,6-tetrakisphosphate in human platelets. Biochem. J. 270, 125-131, 1990.
23. EBERHARD, M., and ERNE, P. Inositol 1,4,5-trisphosphate-induced calcium release in permeabilized platelets is coupled to hydrolysis of inositol 1,4,5-trisphosphate to inositol 1,4-bisphosphate. Biochem. Biophys. Res. Commun. 195, 19-24, 1993.
24. KHAN, W.A., MASCARELLA, S.W., LEWIN, A.H., WYRICK, C.D., CARROLL, F.I., and HANNUN, Y.A. Use of D-erythro-sphingosine as a pharmacological inhibitor of protein kinase C in human platelets. Biochem. J. 278, 387-392, 1991.
25. + exchange activity induced by thrombin is not inhibited by protein kinase inhibitors, staurosporine, K-252a, H-7 and sphingosine in human platelets. Thromb. Res. 70, 139-149, 1993.
26. HASHIZUME, T., SATO, T., and FUJII, T. Sphingosine enhances platelet aggregation through an increase in phospholipase C activity by a protein kinase C-independent mechanism. Biochem. J. 282, 243-247, 1992.